+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 40Years +
All Genders
ID05571059

Randomized Study of Oral Ifetroban Compared to Placebo to Assess Safety and Effects in Patients with Idiopathic Pulmonary Fibrosis

Led by Cumberland Pharmaceuticals · Updated on 2026-09-02

128

Participants Needed

20

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying oral ifetroban to evaluate its safety and effectiveness in treating patients with Idiopathic Pulmonary Fibrosis IPF, a lung disease that causes fibrosis from various causes including genetic factors, bleomycin, and radiation. This phase II, multicenter, randomized, placebo-controlled trial compares daily oral ifetroban to a placebo over 12 months. The study aims to assess lung function changes and other important health outcomes in people with IPF. Participants will be randomly assigned to receive either oral ifetroban 250 mg once daily or a matching placebo, with both groups continuing any stable background antifibrotic or pulmonary hypertension therapies. The treatment period lasts for 12 months, during which participants take their assigned capsules daily. Blood and urine samples will be collected to study standard and novel biomarkers related to progressive pulmonary fibrosis. During the trial, participants will undergo safety monitoring and efficacy assessments, including lung function tests measuring forced vital capacity FVC. Researchers will also track acute exacerbations, hospitalizations, quality of life, and adverse events. The study includes regular evaluations throughout the 12-month period to carefully monitor health status and treatment effects, with a focus on maintaining participant safety and adherence.

CONDITIONS

Brief Title

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Research Team

I

Ines Macias-Perez, PhD

I

Ingrid Anderson, PhD, CCRP

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here